PHF10 inhibits gastric epithelium differentiation and induces gastric cancer carcinogenesis

Zhiyuan Fan, Wenjing Yan, Jianfang Li, Min Yan, Bingya Liu, Zhongyin Yang and Beiqin Yu

Cancer Gene Ther, 2024, 31, 1511
DOI: 10.1038/s41417-024-00820-5

Selection of Nucleotide-Encoded Mass Libraries of Macrocyclic Peptides for Inaccessible Drug Targets

Kilian Colas, Daniel Bindl and Hiroaki Suga

Chem. Rev., 2024, 124, 12213
DOI: 10.1021/acs.chemrev.4c00422

Epigenetics-targeted drugs: current paradigms and future challenges

Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, Renhao Guo, Peng Bai, Shuang Liu, Tingting Li, Yutao Jiang, Shuang Wei, Zhijing Na, Xue Xiao and Da Li

Sig Transduct Target Ther, 2024, 9
DOI: 10.1038/s41392-024-02039-0

Structure-Based identification of a potent KDM7A inhibitor exerts anticancer activity through transcriptionally reducing MKRN1 in taxol- resistant and -sensitive triple-negative breast cancer cells

Jin-Jin Shi, Yan-Jun Liu, Zhi-Guo Liu, Ru-Yi Chen, Ran Wang, Jing Yu, Chang-Yun Li, Guan‑Jun Yang and Jiong Chen

Bioorganic Chemistry, 2024, 153, 107945
DOI: 10.1016/j.bioorg.2024.107945

Macrocyclic Peptide Probes for Immunomodulatory Protein CD59: Potent Modulators of Bacterial Toxin Activity and Antibody‐Dependent Cytotoxicity

Jasmine K. Bickel, Ammar. I. S. Ahmed, Aidan B. Pidd, Rhodri M. Morgan, Tom E. McAllister, Sam Horrell, Emma C. Couves, Hemavathi Nagaraj, Edward J. Bartlett, Kamel El Omari, Akane Kawamura, Doryen Bubeck and Edward W. Tate

Angew Chem Int Ed, 2025, 64
DOI: 10.1002/anie.202422673

Tackling Undruggable Targets with Designer Peptidomimetics and Synthetic Biologics

Colin S. Swenson, Gunasheil Mandava, Deborah M. Thomas and Raymond E. Moellering

Chem. Rev., 2024, 124, 13020
DOI: 10.1021/acs.chemrev.4c00423

Macrocyclic Peptide Probes for Immunomodulatory Protein CD59: Potent Modulators of Bacterial Toxin Activity and Antibody‐Dependent Cytotoxicity

Jasmine K. Bickel, Ammar. I. S. Ahmed, Aidan B. Pidd, Rhodri M. Morgan, Tom E. McAllister, Sam Horrell, Emma C. Couves, Hemavathi Nagaraj, Edward J. Bartlett, Kamel El Omari, Akane Kawamura, Doryen Bubeck and Edward W. Tate

Angewandte Chemie, 2025, 137
DOI: 10.1002/ange.202422673

Recent developments in catalysis and inhibition of the Jumonji histone demethylases

Letitia Sarah and Danica Galonić Fujimori

Current Opinion in Structural Biology, 2023, 83, 102707
DOI: 10.1016/j.sbi.2023.102707

Selective targeting of human TET1 by cyclic peptide inhibitors: Insights from biochemical profiling

Klemensas Šimelis, Hilal Saraç, Eidarus Salah, Kosuke Nishio, Tom E. McAllister, Thomas P. Corner, Anthony Tumber, Roman Belle, Christopher J. Schofield, Hiroaki Suga and Akane Kawamura

Bioorganic & Medicinal Chemistry, 2024, 99, 117597
DOI: 10.1016/j.bmc.2024.117597

Chemical inhibitors targeting histone methylation readers

Xiaolei Huang, Yichang Chen, Qin Xiao, Xinci Shang and Yanli Liu

Pharmacology & Therapeutics, 2024, 256, 108614
DOI: 10.1016/j.pharmthera.2024.108614